mouse rab27a (Addgene inc)
Structured Review

Mouse Rab27a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+rab27a/pmc12562733-52-10-13?v=Addgene+inc
Average 93 stars, based on 4 article reviews
Images
1) Product Images from "Challenges and caveats in manipulating extracellular vesicle secretion from pancreatic cancer cells"
Article Title: Challenges and caveats in manipulating extracellular vesicle secretion from pancreatic cancer cells
Journal: Cancer Biology & Therapy
doi: 10.1080/15384047.2025.2569946
Figure Legend Snippet: Rab27a and Rab35 KO do not impact KPC tumor growth. (a) Schematic of the involvement of Rab27a and Rab35 in EV secretion. (b) Immunoblot validation of Rab27a and Rab35 KO probed for Rab27a, Rab35, and α-tubulin. (c) Particle concentration of EVs derived from WT, Rab27a KO, and Rab35 KO cells. (d) Growth of WT, Rab27a KO, and Rab35 KO cells. (e) Tumor volume, weight, and immunofluorescence staining for Ki-67 in KPC WT, Rab27a KO, and Rab35 KO 14-d orthotopic pancreatic tumors implanted into C57BL6 mice. p -values were calculated using an ordinary one-way ANOVA. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.
Techniques Used: Western Blot, Biomarker Discovery, Concentration Assay, Derivative Assay, Immunofluorescence, Staining
Figure Legend Snippet: Pooled shRab27a does not KD Rab27a. (a) Schematic of EV production through the action of Rab27a. (b) DNA validation of the full Tet-On shRab27a lentiviral construct following transduction. (c) Growth of KPC cells treated with increasing concentrations of dox. (d) Relative Rab27a expression normalized to Gapdh in KPC PalmGRET tCD19 shRab27a cells with siRab27a or dox treatment (+ = 0.6 µg/mL, ++ = 3 µg/mL. (e) Immunoblotting of shRab27a cells after 48 and 72 h of siRNA or 3 µg/mL dox treatment. (f) Relative Rab27a expression normalized to Gapdh in 5 clones with and without 0.3 µg/mL dox treatment. (g) Immunoblotting of shRab27a clone 4 with and without 3 µg/mL dox at 48 and 72 h probed for Rab27a and α-tubulin. (h) Nanoparticle tracking analysis of EVs isolated from shRab27a clone 4 with and without 3 µg/mL dox. p -values were calculated using an unpaired two-tailed Student's t -test. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant.
Techniques Used: Biomarker Discovery, Construct, Transduction, Expressing, Western Blot, Clone Assay, Isolation, Two Tailed Test


